ArticleJournal of oncology2022

A Platinum Resistance-Related lncRNA Signature for Risk Classification and Prognosis Prediction in Patients with Serous Ovarian Cancer.

Yan Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.